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.Background 
       Glucose-6-phosphate dehydrogenase (G6PD) is present in all cells of the body where it is 
involved in pentose phosphate shunt, and it catalyses the oxidation of glucose-6-phosphate to 6-
phosphogluconolactone. This step is necessary for the reduction of hydrogen peroxide. In G6PD 
deficient red cells, oxidative stress can cause hemolysis. In G6PD deficient individuals, the enzyme 
shows a lower concentration than the normal. The enzyme is also present in leukocytes, platelets; 
liver, kidneys and adrenals where the deficiency is not severe to cause the pathological effects since 
there are alternate pathways for the generation of nicotinamide adenine dinucleotide phosphate 
(NADPH) in nucleated cells. Bactericidal activity of neutrophils is decreased and the affected subject 
is prone to repeated infections. In enteric fever, pneumonia and hepatitis, G6PD deficient subjects 
react more severely and hemolysis can complicate the course of disease. Although G6PD deficiency 
associated, hemolysis is the most important manifestation, it is association with cardiac disease, 
diabetes mellitus, hypertension, preeclampsia, aging process and infertility has highlighted its 
importance.  
 
Aim of study: 
    The aim of the study was to determine the prevalence of G6PD deficiency in relation to neonatal 
jaundice. 
 
Subjects,matrerials and methods: 
      A descriptive cross sectional study had been conducted on a convenient sample of one hundred 
seventeen neonates of less than seven-day old. All the cases attending the hospital in Baghdad/Al-
Karkh region (Al-khadaemia pediatric hospital, Al-iskaan teaching pediatric hospital, and Al-yaermok   
teaching  hospital).history taken and physical examination were performing in addition , complete 
blood count, blood film,reticulocyte count ,dirct coombs test total and direct bilirubin level,ABO and 
Rh for mother and neonate and G6PD level was measured for all these neonate. 
 
Results: 
       A descriptive cross sectional study had been conducted on a convenient sample of one hundred 
seventeen neonates of less than seven-day old. All the cases attending the hospital in Baghdad/Al-
Karkh region (Al-khadaemia pediatric hospital, Al-iskaan teaching pediatric hospital, and Al-yaermok   
teaching  hospital. 
     Results showed that (38.46٪) of cases found to be G6PD deficient while  (61.45٪) considered 
normal cases. 
     According to the sex of the neonate we found that boys and girls (66.6%, 33.3%) respectively were 
G6PD deficient, the (p value =0.680), was statistically insignificant according to the sex due to the 
mode of inheritance. All the deficient G6PD enzyme neonates when compare with the total serum 
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bilirubin levels (TSB) begin at TSB 16-17 mg/dl and most of them at TSB level 18- 19 mg⁄dl, they 
divided them into three subgroups,   group one TSB less than 12 mg⁄dl: there is no G6PD deficient 
neonate, groups two TSB 12-19 mg⁄dl: there were 25 G6PD deficient neonates (55.5%),groups three 
TSB ≥ 20 mg⁄dl: there were 20(44.4%) G6PD deficient neonates,  The   p- value =0.0001 which 
highly significant.                             
According to the hemoglobin level (18 ± 4 mg/dl) most of the G6PD deficient neonates were anemic 
the p value = 0.0001. According to the retic count, about 9 (20%) neonate  had 3-4 % retic count, 
11(24.4%) neonate had 5-6%, 7(15.5%) neonate the retic count was 7-8% and in the last 15(40%)  
neonates the retic count were >10% , p- value =0.0001 which highly significant. Regarding the 
treatment we divided the study group into three subgroup, those who need blood exchange therapy 
31(68.8), those who need phototherapy about 11 and those who need no treatment about 3(6.67%). 
The entire deficient neonates (45) only 11(24.4%) showing family history with 34(75.6%) have no 
family history. There was an exclusion a criterion in this study includes ABO and RH incompatibility, 
Haemolytic anaemias other than G6PD deficiency, Cephalhematoma and Sepsis, we depend on the 
combs’ test, blood culture, skull X-ray and pediatrician examination.              
 
Conclutions: 
      In this study, the prevalence of G6PD deficiency in jaundice  newborns was considerably high and 
most of them were non-hemolytic, so we recommend G6PD test as a screening program for every 
newborn at the time of delivery. 
 
Introduction  
     Glucose-6-phosphate dehydrogenase (G6PD) is present in all cells of the body where it is involved 
in pentose phosphate shunt, and it catalyses the oxidation of glucose-6-phosphate to 6-
phosphogluconolactone.
 (1)
 This step is necessary for the reduction of hydrogen peroxide. In G6PD 
deficient red cells, oxidative stress can cause hemolysis.
 (2)
 In G6PD deficient individuals, the enzyme 
shows a lower concentration than the normal. The enzyme is also present in leukocytes, platelets; 
liver, kidneys and adrenals where the deficiency is not severe to cause the pathological effects since 
there are alternate pathways for the generation of nicotinamide adenine dinucleotide phosphate 
(NADPH) in nucleated cells, Bactericidal activity of neutrophils is decreased and the affected subject 
is prone to repeated infections.
 (3)
 In enteric fever, pneumonia and hepatitis, G6PD deficient subjects 
react more severely and hemolysis can complicate the course of disease.
(4)
 Although G6PD deficiency 
associated, hemolysis is the most important manifestation, it is association with cardiac disease, 
diabetes mellitus, hypertension, preeclampsia, aging process and infertility has highlighted its 
importance.
 (5)
  
Aim of study: 
The aim of the study was to determine the prevalence of G6PD deficiency in relation to neonatal 
jaundice. 
 
Subjects,matrerials and methods: 
Patient Inclusion Criteria: 
All of icterius  neonates who were admitted to Children’s Medical Center in AL-Khademia, AL-
Askaan and AL-Yermok teaching hospital from October 2011 to April 2012. We obtained informed 
consent from parents of all participants. 
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Patient Exclusion Criteria: 
1. ABO and RH incompatibility. 
2. Haemolytic anaemias other than G6PD deficiency. 
3. Cephalhematoma. 
4. Sepsis. 
Study Design: 
In our study, 117 neonates (age: 1-7 days) was evaluated. History taking and Physical examination 
was performed. Also CBC, PBS, Retic count, direct Coomb’s test, total and direct bilirubin level, 
Blood group and RH for mother and neonate, and G6PD was performed for all of these neonates. 
These data was entered to computer with SPSS statistical program. We used Chi-square and Anova 
and T-test analysis method for evaluation of statistically significancy. 
Control group: 
Fifty of apparently healthy neonates from different Iraqi populations were randomly included in the 
study. Their age between 1-7 days, of both sexes (male and female), with normal total serum bilirubin 
and no family history. 
METHODS: 
Blood samples collection : 
Divided into: 
1) 2.5 ml of blood put in a potassium EDTA tube for hematocrit, reticulocytes and G6PD activity 
estimation, blood group and RH. 
1 ml of blood put in tube contains 10 IU heparin for enzymatic assay of G6PD. 
Heparinized capillary tube for estimation of total serum bilirubin. 
2) Biochemical investigations: 
Total serum bilirubin for neonates estimated by bilirubinometer. 
3) Hematological investigations: 
Hematocrit (by the micro method) ,Hemoglobin estimation (by Drabkin solution) Blood film and 
Reticulocytes ,corrected counts and Coomb’s test (direct antiglobulin test)were performed manually 
according to Dacie and Lewis
(6)
. 
G6PD screening test (METHAEMOGLOBIN REDUCTION TEST) was performed manually. 
(6)
 
G6PD enzyme assays was performed manually according to method  describe by Beulter et al (1994)
 
(7)
. 
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Results: 
The study included 117 neonates, showed that 45 cases were found to be G6PD deficient while 72 
were considered normal cases as show in figure 1. 
 
 
Figure 1: The G6PD screening test. 
Their  ages around 1-7 days, we found at day one of age 18 babies (25 %) have normal G6PD enzyme 
level, where about 11 babies (24.4%) are deficient, and so at day two 17 babies (23.6%) have normal 
enzyme level and 10 babies (22.2%) are deficient, at day three 9 babies (12.5%) have normal enzyme 
level and 4 babies (8.8%) are deficient, at day fourth 6 babies ( 8.3%) have normal enzyme level and 5 
babies (11.1%) are deficient, at day fifth 8 babies (11.1%) have normal enzyme level and 3 baby 
(6.6%) are deficient, at day sixth 4 babies (5.5%) have normal enzyme level and 8 babies (17.7%) are 
deficient, and at day seventh 10 babies (13.8%) have normal enzyme level and 4 babies (8.8%) are 
deficient, as show in table 1-1 ,according  to the age the( p value = 0.102)  , so it’s insignificant  
according to the age but we found that the rate of deficiency its high at one and two day of age.  
 
According to the sex of the neonate we found that about 47 boys and 25 girls (65.2%, 34.7%) 
respectively, have normal G6PD enzyme level, where as 30 boys and 15 girls (66.6%, 33.3%) 
respectively are deficient, the (p value =0.680), so it’s also insignificant according to the age due to 
the mode of inheritance. 
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Table1: The relation between the ages and sexes of the neonate and their correlation  with level 
of G6PD enzyme according to the Chi-square test. 
 
G6PD enzyme level of the neonate 
P value 
Normal (>10) 
(n=72) 
Deficient (=<10) 
(n=45) 
No % No % 
Age of the neonate(days)  
                                             1 Day 
18 25 11 24.44 
0.449 
2 Days 17 23.6 10 22.22 
3 Days 9 12.5 4 8.89 
4 Days 6 8.3 5 11.11 
5 Days 8 11.11 3 6.67 
6 Days 4 5.56 8 17.78 
7 Days 10 13.89 4 8.89 
            Mean±SD (Min-Max) 3.29±2.11 (1-7) 3.42±2.13 (1-7) 
Sex of the neonate        Boy           47   65.28     30        66.67 
0.878 
    Girl 25 34.7 15 33.33 
All the deficient G6PD enzyme neonates when compare with the total serum bilirubin levels (TSB) 
begin at TSB 16-17 mg/dl and most of them at TSB level 18- 19 mg⁄dl  as showing in the table 2  ,so 
we divided into three subgroups: 
Group one TSB <12 mg⁄dl: there is no G6PD deficient neonate. 
Group two TSB 12-19 mg⁄dl: there are 25 G6PD deficient neonates (55.56%). 
Group  three TSB ≥ 20 mg⁄dl: there are 20 G6PD deficient neonates (44.4%). 
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Table 2: The correlation  between the G6PD enzyme level of the neonate and the total serum 
bilirubin according to the CHI-square test. 
Total serum bilirubin mg/dl 
G6PD enzyme level of the neonate 
P value 
Normal (>10) 
(n=72) 
Deficient (=<10) 
(n=45) 
No % No % 
                                                             <6 5 6.94 - - 
- 
                     6--7 12 16.67 - - 
                     8--9 10 13.89 - - 
                    10--11 14 19.44 - - 
                    12--13 4 5.56 - - 
                    14--15 11 15.28 - - 
                    16--17 11 15.28 8 17.87 
                    18--19 5 6.94 17 37.78 
                    20--21 - - 13 28.89 
                     22--23 - - 7 15.56 
Mean±SD (Min-Max) 11.51±4.26 (3-19) 19.48±1.75 (16-23) 
Serum total and direct bilirubin      <12 41 56.94      - - 
0.0001*                       12-19 31 43.06 25 55.56 
                    ≥20 - - 20 44.44 
 
According to the hemoglobin level (18 ± 4 mg/dl) most of the G6PD deficient neonates are anemic.the 
p value = 0.0001 with a Mean±SD (Min-Max)  = 15.60±1.43 (11-19) for normal neonates and 
12.46±2.76 (8-18) for the deficient G6PD neonates. So it’s significant with the hemoglobin. 
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Table 3: The relationships between G6PD enzyme level and hemoglobin level according to the 
CHI-square. 
 
Haemoglobin level of neonate mg/dl         
G6PD enzyme level of the neonate 
P value 
Normal (>10) 
(n=72) 
Deficient (=<10) 
(n=45) 
No % No % 
 <10 -         -      7 15.56 
0.0001* 
                       10-- - - 7 15.56 
                       11-- 1 1.39 7 15.56 
                       12-- 1 1.39 3 6.67 
                       13-- 3 4.17 9 20 
                      14-- 14 19.44 2 4.44 
                      15-- 19 26.39 3 6.67 
                      16-- 19 26.39 2 4.44 
                      17-- 10 13.89 4 8.89 
                     18-- 4 5.56 1 2.22 
                     19-- 1 1.39 - - 
Mean±SD (Min-Max) 15.60±1.43 (11-19) 12.46±2.76 (8-18) 
 
According  to the reticulocyte  count, about 20% of G6PD enzyme deficient neonates  had 3-4 % retic 
count, 24.4% had  5-6%,15.5.5% the retic count was 7-8% and in the last 15 (40%) neonates the retic 
count were >10% these result were much more than the neonates with the normal enzyme level as 
seen in table 4 . 
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Table 4: The Retic count and G6PD enzyme level of the neonate according to the CHI-square. 
Retic count of the neonate% 
G6PD enzyme level of the neonate 
P value 
Normal (>10) 
(n=72) 
Deficient (=<10) 
(n=45) 
No % No % 
                                 1--2 39 54.17 - - 
0.0001* 
3--4 28 38.89 9 20 
5--6 3 4.17 11 24.44 
7--8 1 1.39 7 15.56 
9--10 1 1.39 3 6.67 
11--12 - - 3 6.67 
13--14 - - 1 2.22 
15--16 - - 3 6.67 
17--18 - - 3 6.67 
19--20 - - 3 6.67 
21-- - - 2 4.44 
Mean±SD (Min-Max) 2.90±1.30 (1-9) 9.68±5.96 (3-26) 
* The Pearson Chi-square statistic is significant at the 0.05 level. 
There is no correlation with the ABO and RH of the neonate and mother with the G6PD deficiency, as 
show in table 5. 
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Table 5: The blood group and RH of the neonate and mother and G6PD enzyme. 
 
G6PD enzyme level of the neonate 
P value 
Normal (>10) 
(n=72) 
Deficient (=<10) 
(n=45) 
No % No % 
Blood group and Rh of the mother       A+ 19 26.4 9 20 
- 
                              A- 2 2.78 - - 
                              B+ 23 31.94 16 35.56 
                              B- 1 1.39 - - 
                             AB+ 12 16.67 9 20 
                             AB- - - - - 
                             O+ 15 20.83 11 24.44 
                             O- - - - - 
Blood group and Rh of the neonate      A+       18 25.0     7 15.5 
- 
                               A- 1 1.39 - - 
                               B+ 24 33.33 18 40 
                               B- 1 1.39 - - 
                              AB+ 13 18.06 11 24.4 
                              AB- - - - - 
                               O+ 14 19.44 9 20 
                               O- 1 1.39 - - 
Regarding the treatment we divided into three subgroup, those who need blood exchange therapy 
31(100%), those who need phototherapy about 11(55%) and those who need no treatment about 
3(4.5%),we find most of the G6PD deficient neonate needing a blood exchange transfusion, its 
significant with the result, the p value=0.0001. 
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The entire deficient neonates (45) only 11 (24.4%) showing family history with 34(75.56%) have no 
family history. 
There was an exclusion a criterion in this study includes ABO and RH incompatibility, Haemolytic 
anaemias other than G6PD deficiency, Cephalhematoma, Sepsis and Breast feeding as a cause of 
neonatal jaundice, we depend on the combs’ test, blood culture, skull X-ray and pediatrician 
examination. 
Discussion: 
     G6PD deficiency is one of the most common red cell enzymopathy reported from almost all 
populations investigated worldwide with polymorphic frequencies in many countries including Iraq 
(8).
 
The results of this study which involved a total of 117samples, (77) males and (40) females, showed 
that 30 male (66.67%) and 15 females neonates (33.33%) cases were found to be G6PD deficient 
while 47 male (65.25%) and 25girl (34.7%) were considered as a normal cases. 
Statistical analyses of this study showed that the most affected neonates ages is in the first day of life 
11(24.4%) and in the sixth day of life 8(17.7%) and the result was insignificantly correlate with the 
age (p value= 0.449), this result was agreed with the study from Abbas Al-omran 1996
(13)
. 
The gene for G6PD deficiency is transmitted as a sex linked trait with severe enzyme deficiency, 
occurring only in hemizygote males and homozygote females. Heterozygous females often have 
normal G6PD activity, but some may have intermediate activity, and others may have low activity 
(9) 
(14).
.  
 Random X-chromosome inactivation results in two RBC populations in female heterozygotes. One 
population consists of RBCs with normal G6PD activity, and the other consists of G6PD-deficient 
cells
(10).
. 
 The X-inactivation may be non-random or one or the other clone may be selected preferentially. 
There may be varying phenotypes, and the RBCs of heterozygotes may exhibit normal, intermediate, 
or grossly deficient G6PD activity
(14)
. 
Thirty percent of the G6PD-deficient neonates is males while fifteen percent is female and the p 
value= 0.878 which is insignificant , which was  more than what was observed by Kaplan and 
Abramov and Abbas Al-Omran, who reported it to be 14%.
(11) (13).
 This high incidence of G6PD 
deficiency in females may be in part due to the high rate of consanguinity among the Iraqi population, 
leading to increased numbers of female homozygotes. In addition, the high frequency of inactivation 
of the normal X-chromosome in female heterozygotes can also lead to disturbance of the Hardy-
Weinberg equilibrium(describes a state in which genotype frequencies are constant from generation to 
generation and in which genotype frequencies are a product of allele frequencies. This condition 
prevails in situations in which there are an absence of mutations, migrations, non-random mating and 
environmental factors favoring particular genotypes.) . 
(15) 
This is study showed a significant difference in the mean bilirubin level between G6PD deficient 
neonates and other icteric neonates, (compared group 2, TSB=12-19 mg/dl and group 3, TSB≥ 20 
mg/dl) (P was = 0.001), It seems that, in severe hyperbilirubinemia (TSB ≥ 20 mg/dl) the prevalence 
of G6PD deficiency is more than in the moderate hyperbilirubinemia (TSB ≥ 12mg/dl) that may be a 
risk factor for some complications as kernicterus.
 
A study from Saudi Arabia by Abbas Al-Omran
(13)
  showed 18.4% prevalence of G6PD deficiency in 
icteric newborns without any signs of hemolysis. Other studies from Singapore
 
 by Koosha 
(16)
  and 
from Iran by Farzaneh 
(17)
, showed that there were no differences in the highest total bilirubin 
concentration (p = 0.7, 0.9 respectively) in the normal and deficient G6PD neonates and results which 
 Al-Kufa University Journal for Biology / VOL.8/ NO.3/ Year: 2016 
 Print ISSN: 2073-8854 & Online ISSN: 2311-6544 
90 URL: http://www.uokufa.edu.iq/journals/index.php/ajb/index                       
http://iasj.net/iasj?func=issues&jId=129&uiLanguage=en                                  
          Email: biomgzn.sci@uokufa.edu.iq 
 
were not agree with this study, while study from Iran by S. Behjati-Ardakani, 2007
(18)
  which showed 
a significant agree with this study (p=0001). 
In the majority of G6PD-deficient infants, the onset of jaundice, as in physiological jaundice, was 
from the first and second day onwards. The age at admission had two peaks, the first on the first day 
of life and the second on the seventh. G6PD-deficient infants are known to have bimodal peaks of 
maximum serum bilirubin concentrations. It is also known that the earlier a hemolytic episode, the 
more pronounced the elevation of serum bilirubin. The course of hyperbilirubinemia may therefore be 
anticipated. 
(19) 
We found a meaningful difference in the mean hemoglobin level between normal and deficient G6PD 
enzyme groups, 25 neonates  had a hemoglobin level of less than 12.0 g/dL with 21 having levels 
more than 13.0 g/dL (p=0.0001), A study from Saudi Arabia (Abbas Al-Omran, May 1996.), from 
Singapore (Koosha A, 2007), and study from Iran (Farzaneh Eghbalian, 2007)
 (13) (16) (17)
, showed that 
there were no differences in the highest total bilirubin concentration  and the lowest haemoglobin 
level between normal G6PD and G6PD  deficient newborns, while study from Iraq (Lauy 
farhood,2004)
 (20)
  show agree with this study.  
These findings do not suggest significant hemolysis as a cause of jaundice in these infants, which is a 
common observation in G6PDdeficient neonates. There is evidence that in the newborn period, 
following exposure to hemolytic agents, jaundice rather than anemia predominates in the clinical 
presentation. Exposure of the newborn infant to a hemolytic agent may be direct or indirect, 
transplacentally, via breast milk, inhalation, or absorption through the skin. 
Reticulocyte counts were less than 10% in ⅔ of the G6PD- deficient neonates while more than 10% in 
⅓ of the G6PD- deficient neonates, all these findings were statistically significant with p 
value=0.0001 which agree with study of Rana Adel Hanoon, 2008
(21)
, as these finding did not suggest 
significant hemolysis as a cause of jaundice in these neonates, which is a common observation in 
G6PD –deficient neonates. 
None of the 45 G6PD deficient neonates had ABO and Rh incompatibility (p=0.757), sepsis and 
cephalhematoma. 
Most of the G6PD deficient patients (24.44%) and other icteric neonates normal G6PD (12.5%) were 
treated with phototherapy; exchange blood transfusion is performed in 31out of 45 G6PD deficient 
neonates (68.89%),as the p value =0.0001 for both treatment. 
In patients with acute haemolysis, the result of G6PD deficiency test may be falsely negative because 
immediately after haemolytic episode, reticulocytes and young erythrocytes predominate. 
Reticulocytes and young erythrocytes have normal or near-normal enzyme activity 
(19) 
The presence of an additional hemolytic process such as ABO incompatibility was found to have little 
impact on the degree of hemolysis and hyperbilirubinemia 
(22)
. These observations confirm those first 
made in Sardinia, where the severity of neonatal jaundice  does not correlate with red cell G6PD 
activity, and the hyperbilirubinemia is largely the result of an impairment of liver function caused by 
G6PD deficiency in the liver 
(22)  
G6PD deficiency is common in Iraq and studies on the frequency of this deficiency and its clinical 
association was scarce, and many aspects on the above issues are still vague. 
Good population data were available from West Africa 
(23)
 , the Mediterranean
(24)
,and from the Far 
East 
(25)
, and it was clear that perhaps as many as one third of all females with neonatal jaundice had 
G6PD deficiency, a similar proportion of male neonates  with G6PD deficiency developed neonatal 
jaundice. Early observations suggested that the incidence of neonatal jaundice  was significantly lower 
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among subjects of African Ancestry in the USA than in Africa, suggesting that environmental as well 
as genetic factors enhance  expression. It is, however, clear that all subjects with G6PD deficiency are 
at increased risk of neonatal jaundice  
 (23)
, and kernicterus has been reported in all at-risk population 
groups. Public health programs had significantly reduce the incidence of kernicterus in some parts of 
the world (e.g. Singapore)
 (26)
  but not others (e.g. Pakistan )
(27)
. 
Some studies have pointed out the higher prevalence, for example Flym et al
(28)
  found that 10% of 
G6PD deficiency was seen in black icteric newborn in the USA Another study in Nigeria, showed that 
40% of icteric newborns were suffering from G6PD deficiency, in most of them there was no 
concomitant hemolysis (Ahmed H, 1999)
 (29)
  ,Madan et al
(30)
 from India showed that in 12.2% of all 
icteric newborns suffered from G6PD deficiency and 48.7% of them had severe jaundice but without 
hemolysis.A study from Saudi Arabia by Yaish H et al 
 (31)
 showed 18.4% prevalence of G6PD 
deficiency in icteric newborns without any signs of hemolysis . 
  Farzaneh et al
(17)
  from Iran did not show a significant difference in the mean bilirubin level between 
G6PD deficient newborns and other icteric newborns . 
In this study, there was statistically significant difference between the prevalence of G6PD deficiency 
and total serum bilirubin level. 
Conclutions: 
In this study, the prevalence of G6PD deficiency in icteric newborns was considerably high and most 
of them were non-hemolytic, so we recommend G6PD test as a screening program for every newborn 
at the time of delivery. 
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